Antimicrobial susceptibility test kit MD0101

for ASTbacteriaclinical

The primary objective of susceptibility testing in clinic is to predict the treatment effect of an infected individual with chosen antimicrobial agents. Results must be derived in a timely manner with a high degree of accuracy and reproducibility. Antimicrobial susceptibility testing (AST) is usually carried out to determine which antimicrobial agent will be most successful in treating a bacterial infection in vivo. Clinical laboratories can choose to determine the susceptibility of bacteria by a number of methods mainly including disc diffusion, dilution (broth microdilution method, broth microdilution method and agar dilution), serial dilution (E-test) minimum inhibitory concentration (MIC) determination1,2, of which can be performed manually or automatically. Clinical Application The MIC of an organism is defined as the minimum amount of antimicrobial agent required to inhibit the growth of the test organism over a specified time interval (which is related to the growth rate of the bacteria). The rapid and accurate determination of the MIC value for an antimicrobial agent/organism combination can significantly improve patient management and prognosis since it enables the prompt administration of appropriate antimicrobial agent therapy. Authoritative Results The Interpretive Categorical Results (SIR) should be interpreted by referring to the latest MIC breakpoint interpretation standard published by CLSI 3 or EUCAST 4